Concepedia

Upulie Divisekera

UD

Statistics

Publications

7

Citations

2.1K

H-Index

7

Active since

2003

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Centre Hospitalier de l’Université de Montréal

St Vincent's Hospital Melbourne

Upulie Divisekera is an author at Peter MacCallum Cancer Centre specializing in oncology, cancer immunotherapy, and antitumor t cell responses.

Publications per year

2003–2014

7

Publications

7

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

John Stagg, Upulie Divisekera, Nicole M. McLaughlin et al. · Proceedings of the National Academy of Sciences · 2010 · 567 citations · Full text

Medicine, Oncology, Pharmacology +17

Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy

John Stagg, Sherene Loi, Upulie Divisekera et al. · Proceedings of the National Academy of Sciences · 2011 · 487 citations

Medicine, Immunology, Oncology +17

CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis

John Stagg, Upulie Divisekera, Helene Duret et al. · Cancer Research · 2011 · 393 citations

Medicine, Immunology, Oncology +17

Blockade of A <sub>2A</sub> receptors potently suppresses the metastasis of CD73 <sup>+</sup> tumors

Paul A. Beavis, Upulie Divisekera, Christophe Paget et al. · Proceedings of the National Academy of Sciences · 2013 · 343 citations · Full text

Life Sciences, Immunology, Oncology +17

CD73-Deficient Mice Are Resistant to Carcinogenesis

John Stagg, Paul A. Beavis, Upulie Divisekera et al. · Cancer Research · 2012 · 201 citations

Medicine, Immunology, Oncology +17

1–5 of 7